In a series of recent decisions, the PTAB denied institution on a dozen petitions on related patents because of one problem it identified in the petitioner’s arguments. All of the petitioner’s proposed grounds challenged the patents under § 103, and all of the grounds relied on the same primary reference, “Aboul-Hosn.” The PTAB found that the petitioner relied on multiple embodiments disclosed in Aboul-Hosn and did not adequately explain how those embodiments were interchangeable or why the skilled person in the art would have found it obvious to combine the teachings of those embodiments. See, e.g., Abiomed, Inc. v. Maquet Cardiovascular, LLC, IPR2017-01204, -01205, Paper 8 at 8-12 (PTAB Oct. 23, 2017); see also Abiomed, Inc. v. Maquet Cardiovascular, LLC, IPR2017-01201, -01202, -01203, Paper 8 at 8-12 (PTAB Oct. 20, 2017); Abiomed, Inc. v. Maquet Cardiovascular, LLC, IPR2017-01207, -01253, Paper 8 at 8-12 (PTAB Oct. 18, 2017); Abiomed, Inc. v. Maquet Cardiovascular, LLC, IPR2017-01025, Paper 8 at 7-11 (PTAB Sept. 26, 2017); Abiomed, Inc. v. Maquet Cardiovascular, LLC, IPR2017-01026, -01027, Paper 8 at 7-11 (PTAB Sept. 20, 2017); Abiomed, Inc. v. Maquet Cardiovascular, LLC, IPR2017-01028, -01029, Paper 8 at 7-11 (PTAB Sept. 20, 2017). (The petitioner has already requested rehearing of several of these decisions, and two other related petitions, IPR2017-01208 and IPR2017-01209, remain pending as of this writing.)
In a decision that is exemplary of all of the PTAB’s decisions on these patents, the PTAB denied institution because it was “unpersuaded that the features of Aboul-Hosn’s various embodiments are interchangeable or that one skilled in the art would have combined those features in the manner proposed by Petitioner.” See Abiomed, IPR2017-01204, -01205, Paper 8 at 11. The petitioner challenged 27 claims as obvious on six different grounds, with each ground relying on Aboul-Hosn as the primary reference. Id. at 3. Aboul-Hosn generally “relates to the transport of fluids between various body regions and the increased stabilization of [a] body organ.” Id. at 9 (citation omitted). According to the PTAB, the petitioner’s challenges cited a combination of two different embodiments of Aboul-Hosn as teaching various features of the claims. Id. One embodiment of Aboul-Hosn describes a “reverse flow pump located external to the vasculature,” while the other embodiment describes an “intravascular axial flow pump.” Id.
The PTAB faulted the petitioner for “treat[ing] the various features of Aboul-Hosn’s different embodiments as if they are interchangeable with one another.” Id. at 10. In the PTAB’s view, the petitioner’s citations to Aboul-Hosn did not support that the embodiments were interchangeable. See id. Moreover, the PTAB found that the petitioner’s expert testimony on what the pump of the second embodiment “could include or would accommodate … is not the same as what Aboul-Hosn teaches. Id. at 11 (emphasis in original). The PTAB further stated that: “Petitioner also fails to provide a sufficient rationale to combine the teachings of Aboul-Hosn’s different embodiments. Petitioner simply fails to explain sufficiently why one skilled in the art would have found it obvious to combine those teachings.” Id. at 11 (emphasis in original). The PTAB denied all proposed grounds based on these deficiencies. Id. at 11-12.
Latest posts by Geoffrey Gavin (see all)
- PTAB Designates Precedential Decision Relating to Infringer’s Civil Action Barring IPR - September 12, 2019
- Federal Circuit Grants Rehearing and Remands IPR to PTAB post-SAS - June 24, 2018
- PTAB Denies Request to Submit Supplemental Information on Skill Level of POSITA - January 26, 2018